COVID-19 Treatment under Aarogyasri EHS Revised Rates for Critical/Non Critical Treatment GO 52 HM&FW Dept. – Revision of existing per day packages for Critical and Non Critical care for treatment of COVID-19 cases under Aarogyasri– Amendment to G.O.Ms.No.77, HM&FW(I.1) Dept., Dt: 08.07.2020 & G.O.MS.No.78, HM&FW (I.1) Dept., Dt.20-07-2020 – Orders- Issued. HEALTH, MEDICAL & FAMILY WELFARE (I) DEPARTMENT G.O.Ms.No.52 Dated.11.05.2021.
3. The CEO, Dr. YSRAHCT, Mangalagiri has furnished proposal for revision of Package prices along with the guidelines for Critical and Non - Critical care for the treatment of COVID-19 cases under Aarogyasri as per the recommendations of both Technical and Expert Committees.
4. Government after careful examination of the proposal, hereby revise the existing per day packages for Critical and Non-Critical care for the treatment of COVID -19 cases under Aarogyasri duly replacing the table mentioned at para-(4)(i) of G.O.Ms.No.77, HM&FW(I.1) Dept, Dt.08.07.2020,with the following :
COVID-19 Treatment under Aarogyasri EHS Revised Rates for Critical/Non Critical Treatment GO 52
Read the following:
- 1. G.O.Rt.No.215, HM&FW(B2) Dept., dt:24.03.2020.
- 2. G.O.Ms.51, HM&FW (I.1) Dept., dt:20.06.2020.
- 3. G.O.Ms.No.77, HM&FW(I.1) Dept., dt: 08.07.2020.
- 4. G.O.MS.No.78, HM&FW (I.1) Dept., Dt.20-07-2020.
- 5. Technical Committee as per GOM meeting on 24.04.2021.
- 6. G.O.RT.No.176, HM&FW (I.1) Dept., Dt.26.04.2021.
- 7. Expert Committee meetings on 27.4.2021 and 28.04.2021.
- 8. From the CEO, Dr. YSRAHCT, Guntur e-file No.YSRAS- 20/3/2021-OPERATIONS-YSRAS, Dated.23.04.2021.
ORDER:
In the reference 5th read above, the CEO, Dr YSRAHCT has furnished the following recommendations of the Technical Committee constituted for revision of existing COVID – 19 packages, in view of unpredictable behavior of the COVID-19 infection.
a. Inclusion of CORADS – 4 (Or) CT severity score of 8/25 for RT – PCR negative cases (Or) in the absence of any RT-PCR report, to consider such patients as COVID positive and take up for treatment.
b. Rs.2500/- to be paid to Government hospitals for ventilator support cases.
In the reference 5th read above, the CEO, Dr YSRAHCT has furnished the following recommendations of the Technical Committee constituted for revision of existing COVID – 19 packages, in view of unpredictable behavior of the COVID-19 infection.
a. Inclusion of CORADS – 4 (Or) CT severity score of 8/25 for RT – PCR negative cases (Or) in the absence of any RT-PCR report, to consider such patients as COVID positive and take up for treatment.
b. Rs.2500/- to be paid to Government hospitals for ventilator support cases.
2. Further, the CEO., Dr. YSR AHCT has also furnished the following per day package rates recommended by the Expert committee constituted in the G.O. 6th read above :
| S.No | Category | Treatment | Proposed rate per day | Proposed rate per day |
| (NABH Hospitals) (In Rs.) | (Non NABH Hospitals) (In Rs.) | |||
| 1 | Non-Critical | Non-Critical COVID 19 Treatment | 4000 | 3600 |
| 2 | Non-Critical COVID 19 Treatment with O2 | 6500 | 5850 | |
| 3 | Critical | ICU with NIV (CPAP, BIPAP, HFNO) | 12000 | 10800 |
| 4 | ICU with ventilator | 16000 | 14400 |
4. Government after careful examination of the proposal, hereby revise the existing per day packages for Critical and Non-Critical care for the treatment of COVID -19 cases under Aarogyasri duly replacing the table mentioned at para-(4)(i) of G.O.Ms.No.77, HM&FW(I.1) Dept, Dt.08.07.2020,with the following :
Revised Rates:
5. Further, in case of RTPCR negative report or in the absence of any RT-PCR report, HRCT report with CORADS 4 & above (Or) CT severity score of 8/25 and above, shall be considered as COVID positive and taken up for treatment.
6. Further, para (4) (xviii) of G.O.Ms.No.77, HM&FW (I.1) Dept., Dt.08.07.2020, is replaced as follows:“For designated COVID 19 Government Hospitals, the PPE and stay cost per day will not be paid. However, Rs.2,500/- can be claimed for the Ventilator support cases.”
7. Further, clause -(i) at para-3 of G.O.Ms.No.78, HM&FW (I.1) Dept., Dt.20.07.2020, is replaced as follows:
“In addition to the High-end drugs like Tocilizumab, Remdesivir and Meropenam, the other treatment modalities excluded from the package are a) Parental Nutrition, b) Plasma Therapy which may be necessary depending upon the severity of the disease, an additional amount is allowed to be paid based on the utilization evidences submitted by the covid treatment hospitals”
8. The same packages shall be applied for all the schemes under Dr YSRAHCT and also for temporarily empaneled hospitals treating COVID.
9. The other guidelines issued vide G.O.MS.No.77, HM&FW(I)Dept, Dt:08.07.2020 and GO.MS.No.78, HM&FW(I) Dept, Dt: 20.07.2020 shall be holds good.
10. The Breakup for the above cost worked out is detailed in Annexure–I and the mandatory investigations which need to be done for each procedure is detailed in Annexure – II of the order. The rate for Parenteral Nutrition and Plasma Therapy will be issued separately.
11. The Chief Executive Officer, Dr YSR AHCT and all DMHOs shall ensure to follow guidelines scrupulously and disciplinary action shall be initiated in case of violations. 12. This order issues with the concurrence of Finance Dept., vide their U.O.No.FIN01 - FMU0MISC / 168 / 2021 – FMU - HMFW (Computer No.1403250), Dt:10.05.2021.
| S.No | Category | Treatment | Proposed rate per day | Proposed rate per day |
| (NABH Hospitals) (In Rs.) | (Non-NABH Hospitals) (In Rs.) | |||
| 1 | Non-Critical | Non-Critical COVID 19 Treatment | 4000 | 3600 |
| 2 | Non-Critical COVID 19 Treatment with O2 | 6500 | 5850 | |
| 3 | Critical | ICU with NIV (CPAP, BIPAP, HFNO) | 12000 | 10800 |
| 4 | ICU with ventilator | 16000 | 14400 |
5. Further, in case of RTPCR negative report or in the absence of any RT-PCR report, HRCT report with CORADS 4 & above (Or) CT severity score of 8/25 and above, shall be considered as COVID positive and taken up for treatment.
6. Further, para (4) (xviii) of G.O.Ms.No.77, HM&FW (I.1) Dept., Dt.08.07.2020, is replaced as follows:“For designated COVID 19 Government Hospitals, the PPE and stay cost per day will not be paid. However, Rs.2,500/- can be claimed for the Ventilator support cases.”
7. Further, clause -(i) at para-3 of G.O.Ms.No.78, HM&FW (I.1) Dept., Dt.20.07.2020, is replaced as follows:
“In addition to the High-end drugs like Tocilizumab, Remdesivir and Meropenam, the other treatment modalities excluded from the package are a) Parental Nutrition, b) Plasma Therapy which may be necessary depending upon the severity of the disease, an additional amount is allowed to be paid based on the utilization evidences submitted by the covid treatment hospitals”
8. The same packages shall be applied for all the schemes under Dr YSRAHCT and also for temporarily empaneled hospitals treating COVID.
9. The other guidelines issued vide G.O.MS.No.77, HM&FW(I)Dept, Dt:08.07.2020 and GO.MS.No.78, HM&FW(I) Dept, Dt: 20.07.2020 shall be holds good.
10. The Breakup for the above cost worked out is detailed in Annexure–I and the mandatory investigations which need to be done for each procedure is detailed in Annexure – II of the order. The rate for Parenteral Nutrition and Plasma Therapy will be issued separately.
11. The Chief Executive Officer, Dr YSR AHCT and all DMHOs shall ensure to follow guidelines scrupulously and disciplinary action shall be initiated in case of violations. 12. This order issues with the concurrence of Finance Dept., vide their U.O.No.FIN01 - FMU0MISC / 168 / 2021 – FMU - HMFW (Computer No.1403250), Dt:10.05.2021.
